Consun Pharmaceutical Group Ltd.'s total assets for Q4 2024 were ¥5.85B, an increase of 6.62% from the previous quarter. HK:1681 total liabilities were ¥1.46B for the fiscal quarter, a -2.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.